ARCHIVES

In Congress: Could NCI Make Use Of Increase? Porter Asks; “We Can Handle It Well,” Klausner Replies

This article is from The Cancer Letter archive.

Vol. 24 No. 13 | April 3, 1998

Download PDF Visit The Full Archive

Related Articles

In Brief: US Pharmacopeia Names Advisory Panel For Hematologic And Oncological Disease

May 31, 1996

Group trials need prioritization, review, NCI official says.

July 25, 2003

Clinton R&D Budget Amounts to a Cut, AAAS Study Says

April 18, 1997

Avastin Combination Approved For Metastatic Colorectal Cancer

February 22, 2013

RAC Grumbles, Gives Healy Guidelines For Compassionate Use Of Gene Therapy

January 22, 1993

In Brief: Kenneth Olden Named Director Of Howard Cancer Center; Calhoon Sparked AMA On Cigarette Ads

February 21, 1986